These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 19633845)

  • 1. Assessment of the pre-clinical immunogenicity of a new VEGF receptor Fc-fusion protein FP3 with ELISA and BIACORE.
    Wang H; Shi J; Wang Q; Li H; Cai K; Hou X; Li T; Zhong Q; Yu D
    Cancer Immunol Immunother; 2010 Feb; 59(2):239-46. PubMed ID: 19633845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble vascular endothelial growth factor decoy receptor FP3 exerts potent antiangiogenic effects.
    Yu DC; Lee JS; Yoo JY; Shin H; Deng H; Wei Y; Yun CO
    Mol Ther; 2012 May; 20(5):938-47. PubMed ID: 22273580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical immunogenicity testing using anti-drug antibody analysis of GX-G3, Fc-fused recombinant human granulocyte colony-stimulating factor, in rat and monkey models.
    Kim YJ; Koh EM; Song CH; Byun MS; Choi YR; Jeon EJ; Hwang K; Kim SK; Yang SI; Jung KJ
    Sci Rep; 2021 Jun; 11(1):12004. PubMed ID: 34099775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor effect of FP3 in combination with cetuximab on patient-derived tumor tissue xenograft models of primary colon carcinoma and related lymphatic and hepatic metastases.
    Dong X; Jin K; Hu X; Du F; Lan H; Han N; Ma Z; Xie B; Cui B; Teng L; Cao F
    Int J Mol Med; 2012 Jul; 30(1):126-32. PubMed ID: 22505231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An HIV Envelope gp120-Fc Fusion Protein Elicits Effector Antibody Responses in Rhesus Macaques.
    Shubin Z; Li W; Poonia B; Ferrari G; LaBranche C; Montefiori D; Zhu X; Pauza CD
    Clin Vaccine Immunol; 2017 Jun; 24(6):. PubMed ID: 28404572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor effects of FP3 in combination with capecitabine on PDTT xenograft models of primary colon carcinoma and related lymphatic and hepatic metastases.
    Jin K; Lan H; Xie B; He K; Xu Z; Li G; Han N; Teng L; Cao F
    Cancer Biol Ther; 2012 Jul; 13(9):737-44. PubMed ID: 22617773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of an immunoassay for human-specific quantitation of therapeutic antibodies in serum samples from non-human primates.
    Stubenrauch K; Wessels U; Lenz H
    J Pharm Biomed Anal; 2009 May; 49(4):1003-8. PubMed ID: 19250787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor effect of FP3 on a patient-derived tumor tissue xenograft model of rectal carcinoma.
    Bi T; Bi T; Lan H; Hu X; Zhu M; Xu Z; Hu J; Teng L; Jin K
    Hepatogastroenterology; 2013; 60(128):1950-4. PubMed ID: 24719933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of immunogenicity of romiplostim in clinical studies with ITP subjects.
    Jawa V; Hokom M; Hu Z; El-Abaadi N; Zhuang Y; Berger D; Gupta S; Swanson SJ; Chirmule N
    Ann Hematol; 2010 Jul; 89 Suppl 1(Suppl 1):75-85. PubMed ID: 20155267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced elicitation of potent neutralizing antibodies by the SARS-CoV-2 spike receptor binding domain Fc fusion protein in mice.
    Liu X; Drelich A; Li W; Chen C; Sun Z; Shi M; Adams C; Mellors JW; Tseng CT; Dimitrov DS
    Vaccine; 2020 Oct; 38(46):7205-7212. PubMed ID: 33010978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant anti-vascular endothelial growth factor fusion protein efficiently suppresses choridal neovasularization in monkeys.
    Zhang M; Zhang J; Yan M; Li H; Yang C; Yu D
    Mol Vis; 2008 Jan; 14():37-49. PubMed ID: 18246030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacology study of a new recombinant human VEGF receptor-fc fusion protein on experimental choroidal neovascularization.
    Zhang M; Yu D; Yang C; Xia Q; Li W; Liu B; Li H
    Pharm Res; 2009 Jan; 26(1):204-10. PubMed ID: 18854954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology study of a chimeric decoy receptor trap fusion protein on retina neovascularization by dual blockage of VEGF and FGF-2.
    Jiang J; Xu K; Wang L; Xin W; Zhao G; Huang M; Li S; Luan X; Fang J
    Eur J Pharm Sci; 2018 Aug; 121():251-259. PubMed ID: 29715501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in systemic vascular endothelial growth factor levels after intravitreal injection of aflibercept in infants with retinopathy of prematurity.
    Huang CY; Lien R; Wang NK; Chao AN; Chen KJ; Chen TL; Hwang YS; Lai CC; Wu WC
    Graefes Arch Clin Exp Ophthalmol; 2018 Mar; 256(3):479-487. PubMed ID: 29290015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity screening assay development for a novel human-mouse chimeric anti-CD147 monoclonal antibody (Metuzumab).
    Mi L; Li W; Li M; Chen T; Wang M; Sun L; Chen Z
    J Immunol Methods; 2016 Jun; 433():38-43. PubMed ID: 26944771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgG-enzyme fusion protein: pharmacokinetics and anti-drug antibody response in rhesus monkeys.
    Boado RJ; Hui EK; Lu JZ; Pardridge WM
    Bioconjug Chem; 2013 Jan; 24(1):97-104. PubMed ID: 23249376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IBI302, a promising candidate for AMD treatment, targeting both the VEGF and complement system with high binding affinity in vitro and effective targeting of the ocular tissue in healthy rhesus monkeys.
    Ren X; Li J; Xu X; Wang C; Cheng Y
    Exp Eye Res; 2016 Apr; 145():352-358. PubMed ID: 26919788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulating immunogenicity of factor IX by fusion to an immunoglobulin Fc domain: a study using a hemophilia B mouse model.
    Levin D; Lagassé HA; Burch E; Strome S; Tan S; Jiang H; Sauna ZE; Golding B
    J Thromb Haemost; 2017 Apr; 15(4):721-734. PubMed ID: 28166609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FP3: a novel VEGF blocker with anti-angiogenic and anti-tumor effects.
    Gao W; Jin K; Lan H; Han N; Cao F; Teng L
    Hepatogastroenterology; 2012; 59(120):2543-7. PubMed ID: 22534543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunogenicity of recombinant adeno-asscociated virus type 1 expressing HIV-1 gp120 gene in mice and Rhesus macaques].
    Yu SQ; Feng X; Liu HM; Yang HR; Li HX; Zeng Y
    Bing Du Xue Bao; 2010 Mar; 26(2):115-20. PubMed ID: 20480640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.